Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayMar 21, 2017 12:40 pm

NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating, $3 PT on Achaogen, Inc. (NASDAQ: AKAO)

Aegis Capital has reiterated a ‘Buy’ rating and price target of $29 on shares of Achaogen’s (NASDAQ: AKAO) stock. The biopharmaceutical company recently reported financial results for the fourth quarter and year ended December 31, 2016, posting total Q4 contract revenue of $10.7 million, which was less than expected. Analysts cited the company’s uneventful fourth quarter in the report, but mentioned that milestones and catalysts are more important in evaluating clinical-stage development companies. Achaogen also recently released an update on its lead product candidate, Plazomicin, which has shown positive results in two phase 3 clinical trials. The company plans to…

Continue Reading

TuesdayMar 21, 2017 11:37 am

NetworkNewsBreaks – CytoDyn Inc.’s (CYDY) PRO 140 Demonstrates Considerable Potential as HIV Treatment

Though considerable advances have been made in the prevention and treatment of HIV/AIDS, more than 1.2 million people in the U.S. are still affected by the disease. CytoDyn Inc.’s (OTCQB: CYDY) PRO 140 candidate is considered one of the most advanced experimental monoclonal antibodies for HIV treatment, and it has been used in more than 140 HIV-positive patients in placebo-controlled and open label FDA-approved clinical trials. “The drug has been the subject of seven clinical trials, each demonstrating efficacy by significantly reducing or controlling HIV viral load in human test patients and has been designated a ‘fast track’ product candidate…

Continue Reading

TuesdayMar 21, 2017 10:37 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Subsidiary Teams with Planet Payment to Offer Multi-Currency Pricing

Mobile payment technology company Net Element, Inc. (NASDAQ: NETE) this morning announced that its Unified Payments subsidiary has entered into a strategic partnership with Planet Payment, Inc. (NASDAQ: PLPM), a leading provider of international and multi-currency payment processing services. Through this agreement, Unified Payments will offer Planet Payment’s Multi-Currency Pricing to its portfolio of online merchants, enabling them to more effectively expand into foreign markets by displaying pricing and accepting payments in a variety of local currencies. “We are excited to form this partnership with Planet Payment to bring our online merchants the ability to price in multiple currencies and…

Continue Reading

TuesdayMar 21, 2017 9:58 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Files Provisional Patent for Treatment of Eating Disorders Using Cannabis Extracts

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its filing of a provisional patent for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds. Should this filing result in the issuance of a patent, IGC intends to develop its IGC-506 candidate for both human and veterinary use. “The development of cannabis-based combination therapies represents a large, unique opportunity, and we believe we are the first mover in this emerging specialty-pharmaceutical sector,” Ram Mukunda, chief executive officer…

Continue Reading

MondayMar 20, 2017 1:34 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 20, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ATLT 20.00% – News: Expects significant gains for Q3 ended March 31, 2017 NMUS 18.37% – News: Signs development agreement with Nanomerics Ltd. for ocular formulation NB1111 AKDS 15.79% – News: Inks LOI to acquire SolBright Renewable Energy GLBR 13.79% – News: Posts Q4 2016 results COYN 8.36% – News:  COPsync Network continues to grow ALQA 8.10% – News: Peer-reviewed study on MIST Therapy for deep tissue pressure injuries published in Wound Repair &…

Continue Reading

MondayMar 20, 2017 12:15 pm

NetworkNewsBreaks – BioLineRx (NASDAQ: BLRX) Reports Interim Results on Phase 2 Study of BL-8040 in Stem Cell Mobilization

BioLineRx (NASDAQ: BLRX) this morning reported partial results data from its open-label phase 2 trial for BL-8040 as a novel monotherapy approach for the mobilization and collection of blood forming stem and progenitor cells from the peripheral blood. Interim results from the initial cohort of donor and recipient pairs show that a single injection of BL-8040 mobilized sufficient amounts of cells required for transplantation at a level of efficacy similar to that achieved by using 4-6 injections of G-CSF, the current standard of care. So far, all transplant recipients have experienced a successful neutrophil engraftment. Recipients will continue to be…

Continue Reading

MondayMar 20, 2017 11:50 am

NetworkNewsBreaks – Cerulean Pharma (NASDAQ: CERU) Shares Dive on Stock Purchase Agreement with Daré Bioscience

Shares of Cerulean Pharma (NASDAQ: CERU) dropped 60% this morning after the company said it entered a definitive stock purchase agreement with Daré Bioscience, Inc. under which the equityholders of Daré will become the majority owners of Cerulean. The transaction will result in a public, Nasdaq-listed company focused on the development and commercialization of products for women’s reproductive health. Daré’s product candidate, Ovaprene®, is a clinical stage, non-hormonal contraceptive ring for monthly use that potentially addresses a significant unmet need in the $16 billion global contraception market. The combined company will operate under the name Daré; its CEO will be…

Continue Reading

MondayMar 20, 2017 11:47 am

NetworkNewsBreaks – FuelCell Energy, Inc. (NASDAQ: FCEL) Attends Dedication of Another Fuel Cell Park by Partner POSCO Energy in Seoul

FuelCell Energy (NASDAQ: FCEL) shares are ticking higher after the company announced the dedication event of the Noeul Green Energy Co. fuel cell park in Seoul, South Korea. The 20 megawatt fuel cell park supplies ultra-clean power to the electric grid and high quality heat to a district heating system and was constructed by the company’s South Korean partner POSCO Energy in just 10 months. Members of FuelCell Energy’s executive management joined POSCO Energy executives, government officials and customers to celebrate the operation of this fuel cell park. “This project exemplifies the benefits of fuel cell installations by locating the…

Continue Reading

MondayMar 20, 2017 11:43 am

NetworkNewsBreaks – Medical Transcription Billing, Corp. (NASDAQ: MTBC) Announces Monthly Dividend on Series A Preferred Stock

Health care information technology company Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) this morning announced that its board of directors has declared monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock for March, April and May of this year. Holders of these shares are entitled to receive cumulative cash dividends at the rate of 11% of the $25 per share liquidation preference per annum, which is equivalent to $2.75 per year per share. The applicable record date related to this dividend will be the last day of the calendar month, with the dividend becoming payable on…

Continue Reading

MondayMar 20, 2017 10:22 am

NetworkNewsBreaks – Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) SAGA Trial Fails to Reach Primary Endpoint; Shares Plummet

Shares of Aevi Genomic Medicine (NASDAQ: GNMX) dropped 60% shortly after market open on news that the company’s AEVI-001 did not meet the primary endpoint of reduction on the ADHD rating scale (ADHD-RS) compared to placebo; however, there was improvement observed on the inattention subscale. The results also show efficacy and benefit to patients in two pre-specified responder analyses: ADHD-RS improvement of 30% or more, which was met by 70% of patients treated with AEVI-001 versus 42% on placebo; and Clinical Global Impression of Improvement scale (CGI-I), resulting in 57% of patients treated with AEVI-001 achieving a score of much…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000